Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 253

1.

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ; Protocol 007 Study Group.

Rheumatology (Oxford). 2002 Sep;41(9):1052-61. Erratum in: Rheumatology (Oxford). 2003 Jun;42(6):814.

PMID:
12209041
[PubMed - indexed for MEDLINE]
Free Article
2.

A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.

Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE; etoricoxib OA study group.

Curr Med Res Opin. 2003;19(8):725-36. Erratum in: Curr Med Res Opin. 2004 Oct;20(10):1689.

PMID:
14687444
[PubMed - indexed for MEDLINE]
3.

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.

Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, Ko A, Cichanowitz N, Reicin AS.

Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16.

PMID:
17631392
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.

Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, Castro R, Sanchez M, Detora LM, Ng J.

Curr Med Res Opin. 2002;18(2):49-58.

PMID:
12017209
[PubMed - indexed for MEDLINE]
5.

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.

van der Heijde D, Baraf HS, Ramos-Remus C, Calin A, Weaver AL, Schiff M, James M, Markind JE, Reicin AS, Melian A, Dougados M.

Arthritis Rheum. 2005 Apr;52(4):1205-15.

PMID:
15818702
[PubMed - indexed for MEDLINE]
Free Article
6.

Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.

Rheumatology (Oxford). 2007 Mar;46(3):496-507. Epub 2006 Aug 27.

PMID:
16936327
[PubMed - indexed for MEDLINE]
Free Article
7.

A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.

Matsumoto AK, Melian A, Mandel DR, McIlwain HH, Borenstein D, Zhao PL, Lines CR, Gertz BJ, Curtis S; Etoricoxib Rheumatoid Arthritis Study Group.

J Rheumatol. 2002 Aug;29(8):1623-30.

PMID:
12180720
[PubMed - indexed for MEDLINE]
8.

Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].

Curtis SP, Bockow B, Fisher C, Olaleye J, Compton A, Ko AT, Reicin AS.

BMC Musculoskelet Disord. 2005 Dec 1;6:58.

PMID:
16321158
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.

Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS.

Ann Rheum Dis. 2007 Jul;66(7):945-51. Epub 2006 Dec 1.

PMID:
17142385
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.

Fleischmann R, Sheldon E, Maldonado-Cocco J, Dutta D, Yu S, Sloan VS.

Clin Rheumatol. 2006 Feb;25(1):42-53. Epub 2005 Aug 13.

PMID:
16132165
[PubMed - indexed for MEDLINE]
11.

Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.

Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, Aversano ML, Reicin AS; Protocol 071 Study Group.

Mayo Clin Proc. 2005 Apr;80(4):470-9.

PMID:
15819283
[PubMed - indexed for MEDLINE]
13.

Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).

Krueger K, Lino L, Dore R, Radominski S, Zhang Y, Kaur A, Simpson R, Curtis S.

Ann Rheum Dis. 2008 Mar;67(3):315-22. Epub 2007 Oct 27. Erratum in: Ann Rheum Dis.2008 May;67(5):732.

PMID:
17965424
[PubMed - indexed for MEDLINE]
14.

Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.

Sheldon E, Beaulieu A, Paster Z, Dutta D, Yu S, Sloan VS.

Clin Ther. 2005 Jan;27(1):64-77.

PMID:
15763607
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.

Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B.

Osteoarthritis Cartilage. 2010 May;18(5):629-39. doi: 10.1016/j.joca.2009.12.013. Epub 2010 Feb 16.

PMID:
20202489
[PubMed - indexed for MEDLINE]
Free Article
16.

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.

Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E.

Arch Intern Med. 2000 Jun 26;160(12):1781-7.

PMID:
10871971
[PubMed - indexed for MEDLINE]
17.

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.

Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N.

J Rheumatol. 2000 Nov;27(11):2635-41.

PMID:
11093446
[PubMed - indexed for MEDLINE]
18.
19.

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.

Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS.

Curr Med Res Opin. 2005 Apr;21(4):517-26.

PMID:
15899100
[PubMed - indexed for MEDLINE]
20.

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.

Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, Bliddal H, Uebelhart D, Adami S, Navarro F, Lee A, Moore A, Gimona A.

Ann Rheum Dis. 2004 Nov;63(11):1419-26. Epub 2004 Feb 27.

PMID:
15020310
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk